IRVING, Texas--(EON: Enhanced Online News)--Vizient, Inc. announced today that it will participate in three educational sessions at the ASHP 2016 Midyear Clinical Meeting and Exhibition, December 4-8 in Las Vegas, Nevada. With its focus on improving patient care and medication safety, the ASHP event is expected to be attended by more than 20,000 pharmacy professionals from around the globe.
“It is exciting to participate at ASHP’s midyear event and to help fellow pharmacy practitioners advance their understanding of critical issues such as biosimilars and antimicrobial stewardship”
Vizient’s Steven Lucio, Pharm.D., BCPS, Associate Vice President Clinical Solutions and Pharmacy Program Development will participate in two sessions focused on biosimilars. Kristi Kuper, Pharm.D., BCPS, Senior Clinical Manager will lead a session on antibiotic stewardship. Vizient will also participate in the exhibition at booth 1275.
“It is exciting to participate at ASHP’s midyear event and to help fellow pharmacy practitioners advance their understanding of critical issues such as biosimilars and antimicrobial stewardship,” said Lucio. “It is also a great environment in which to share the innovative work accomplished by Vizient member organizations.”
The presentations Vizient will participate in are:
Out of the Gate: What Are the Latest Developments?
Monday, December 5, 11:30 a.m. - 1:00 p.m. PT (live and satellite event)
A discussion of the current status of biosimilar development in the
United States, including the FDA approval pathway for biosimilars, FDA
draft guidance documents on product labeling and interchangeability,
diagnostic criteria and prescribing practices and pending approvals.
Lucio will co-present with Kami Roake, Pharm.D., Rheumatology &
Gastroenterology Pharmacist, University of Utah Hospital & Clinics
CE Credit: 1.50 hours
Online Registration: http://www.proce.com/activities/activity_detail?id=508
Savings: Lowering Prices, But Who Saves Money?
Tuesday, December 6, 10:00 – 11:00 a.m. PT, Mandalay Bay J, Level 2
A discussion of the opportunities for cost savings with biosimilars
based on the European experience as well as the initial competing
biologics approved in the U.S. and the anticipated approach of Medicare,
Medicaid, private payers, and other entities and how these strategies
will affect pharmaceutical costs. Lucio will co-present with Molly
Leber, Pharm.D., BCPS, FASHP, Manager Medication Policy and Formulary
Management, Yale New Haven Health System.
CE Credit: 1 hour
Stewardship: Innovative Practices in the Community Hospital Setting
Wednesday, December 7, 2:00 – 4:00 p.m. PT, Mandalay Bay, Lagoon L, Level 2
A review and discussion of recent national legislative and policy efforts related to antibiotic stewardship, innovative antibiotic stewardship practices that can be implemented in the community hospital setting, technology to assist with antimicrobial stewardship efforts, and strategies used to engage private practice physicians in stewardship activities. Vizient’s Kristi Kuper will moderate this session with the following panelists:
- David Ha, Pharm.D., Assistant Professor of Clinical Sciences, Keck Graduate Institute School of Pharmacy, Infectious Diseases Pharmacist Specialist, Pomona Valley Hospital
- Amy Schilling, Pharm.D., BCPS, Clinical Pharmacist, Memorial Hermann
- Montgomery F. Williams, Pharm.D., BCPS, Assistant Professor of Pharmacy Practice, Belmont University College of Pharmacy; Clinical Pharmacist, Internal Medicine and Antimicrobial Stewardship, Williamson Medical Center
CE Credit: 2 hours
For more information about Vizient and its pharmacy advisory services and pharmacy program, visit www.vizientinc.com
About Vizient, Inc.
Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient serves a diverse membership and customer base which includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents almost $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as the recently acquired MedAssets’ Spend and Clinical Resource Management (SCM) segment, which includes Sg2. In 2016, Vizient received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient headquarters is based in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.